XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.24.3

Organization and Summary of Significant Accounting Policies (Details) - Schedule of Research and Development Expense - USD ($) | 9 Months Ended
--- | ---
Sep. 30, 2024 | Sep. 30, 2023
Schedule of Research and Development Expense [Abstract] |  |
Fair value of 8,000,000 shares Dragon shares transferred based on recent sales of Dragon shares at $0.30 per share | $ 2,400,000 |
Less: gain recognized as difference between fair value of 8,000,000 shares calculated above and allocated costs of investment in Dragon and included in research and development | (2,233,333) |
Research and development expense recorded, net | $ 166,667 | $ 63,801

X
- Definition Less gain recognized as difference between fair value of shares + References No definition available. + Details
Name: | dats_LessGainRecognizedAsDifferenceBetweenFairValueOfShares
Namespace Prefix: | dats_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and Development Fair Value. + References No definition available. + Details
Name: | dats_ResearchandDevelopmenFairValue
Namespace Prefix: | dats_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of other research and development expense. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1 + Details
Name: | us-gaap_OtherResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentExpenseAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration